MedPath

MINT-SOLIFENACIN

MINT-SOLIFENACIN

Discontinued
DIN Number

02443198

Drug Class

Human

Market Date

Apr 20, 2016

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02443198
AIG Number0151584002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04BD08 SOLIFENACIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification86:12.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

SOLIFENACIN SUCCINATEActive
Strength: 10 MG
Monograph: SOLIFENACIN SUCCINATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.